Pacira BioSciences (PCRX) Amortizatization of Intangibles (2010 - 2026)

Pacira BioSciences' (PCRX) quarterly Amortizatization of Intangibles came in at $570000.0 in Q1 2026, down 70.16% year-on-year from $1.9 million in Q1 2025, and down 88.19% quarter-over-quarter from $4.8 million in Q4 2025.

Pacira BioSciences (PCRX) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends

Pacira BioSciences' Amortizatization of Intangibles history runs 17 years deep, the most recent figure standing at $570000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 70.16% year-over-year to $570000.0 in Q1 2026; TTM through Mar 2026 was $5.5 million, a 41.17% decrease from a year earlier, with the FY2025 full-year figure at $4.9 million, down 33.61% from the prior year.
  • Amortizatization of Intangibles declined to $570000.0 in Q1 2026 per PCRX's latest filing, from $4.8 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $7.4 million in Q4 2024 and bottomed at $23000.0 in Q2 2024.
  • The 5-year median for Amortizatization of Intangibles is $675000.0 (2023), against an average of $1.3 million.
  • Across the five-year window, Amortizatization of Intangibles slumped 96.44% in 2024 and soared 7858.33% in 2025, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $700000.0 in 2022, then surged by 449.71% to $3.8 million in 2023, then surged by 91.03% to $7.4 million in 2024, then tumbled by 34.35% to $4.8 million in 2025, then slumped by 88.19% to $570000.0 in 2026.
  • Per Business Quant, the three latest PCRX Amortizatization of Intangibles figures stand at $570000.0 (Q1 2026), $4.8 million (Q4 2025), and $56000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Pacira BioSciences 1.08 Bn 876.91 Mn 140.96 Mn 570,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 570,000.00
Mar 31, 2026 570,000.00
Dec 31, 2025 4.83 Mn
Dec 31, 2025 4.83 Mn
Sep 30, 2025 56,000.00
Sep 30, 2025 56,000.00
Jun 30, 2025 23,000.00
Jun 30, 2025 23,000.00
Mar 31, 2025 1.91 Mn
Mar 31, 2025 1.91 Mn
Dec 31, 2024 7.35 Mn
Dec 31, 2024 7.35 Mn
Sep 30, 2024 23,000.00
Sep 30, 2024 23,000.00
Jun 30, 2024 23,000.00
Jun 30, 2024 23,000.00
Mar 31, 2024 24,000.00
Mar 31, 2024 24,000.00
Dec 31, 2023 3.85 Mn
Dec 31, 2023 3.85 Mn